Ofir Hazut

Ofir Hazut serves as the VP of Medical Investments at The Trendlines Group since January 2020, where the organization invests in innovative medical and agricultural technologies. Additionally, Ofir is a board member for multiple companies, including ZygoFix, Dasyo, Omeq Medical, Seger Surgical Solutions, Occutrack, Medulla pro, Nasotrack, NICE, STEP, and Ayzersense. Previous experience includes roles as Director of Business Development at Evogene, CEO of MEway Medical, Principal at Agate Medical Investments Group, and VP of Business Development at DiagnosticAid. Ofir's educational background includes a Master’s degree in Neuroscience and an MBA in Information Technology from Bar-Ilan University, along with a B.Sc. in Neuroscience from the same institution.